January 8th 2025
The FDA approved the addition of Guillain-Barré syndrome warnings for Abrysvo and Arexvy, citing postmarketing data suggesting an increased risk.
December 18th 2024
COVID-19 Vaccine Update: Coadministration, Myocarditis Risk, Adolescents, Foreign Vaccination
July 6th 2021The ACIP green lights mRNA vaccines with warning for myocarditis and pericarditis, says COVID-19 vaccine can be given on the same day as other common vaccines, advises COVID vaccine for all aged ≥12 yrs.